David Lamond's Net Worth
$1.61 Million
Who is David Lamond?
David Lamond has an estimated net worth of $1.61 Million. This is based on reported shares across multiple companies, which include Applied Molecular Transport Inc., Quince Therapeutics, Inc., and Lucira Health, Inc..
SEC CIK
David Lamond's CIK is 0001770790
Past Insider Trading and Trends
2022 was David Lamond's most active year for acquiring shares with 3 total transactions. David Lamond's most active month to acquire stocks was the month of May. 2019 was David Lamond's most active year for disposing of shares, totalling 1 transactions. David Lamond's most active month to dispose stocks was the month of April. 2023 saw David Lamond paying a total of $22,773.54 for 49,327 shares, this is the most they've acquired in one year. In 2019 David Lamond cashed out on 301,829 shares for a total of $0.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Applied Molecular Transport Inc. (AMTI) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 24
| |||
Form 4
| +6.58% | 66.5K |
$3.17 | $210,850.00 | 1.08M |
May 20 - May 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 18
| |||
Form 4
| +2.54% | 25K |
$42.00 | $1,050,000.00 | 1.01M |
Apr 6
| |||
Form 4
|
∞
| 986.02K |
$14.00 |
—
| 986.02K |
Jun 9
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Quince Therapeutics, Inc. (QNCX) Snapshot price: $0.71
InvestorDavid Lamond owns 2,302,291 units of Common Stock which is worth $1,634,626.61. From 2019 to 2024 David Lamond acquired a total of 324,156 shares in Quince Therapeutics, Inc. at a cost of $22,773.54.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 5
| |||
Form 4
| +0.99% | 67.88K |
$1.01 | $69,232.62 | 6.93M |
Dec 12 - Dec 14
| |||
Form 4
| +2.58% | 57.37K |
$1.01 | $58,133.92 | 2.28M |
Dec 5 - Dec 7
| |||
Form 4
| +1.98% | 43.13K |
$0.94 | $40,545.96 | 2.22M |
Nov 29 - Dec 1
| |||
Form 4
| +3.91% | 82.05K |
$1.32 | $107,898.38 | 2.18M |
Aug 30 - Aug 31
| |||
Form 4
| +13.53% | 250K |
$1.30 | $325,736.58 | 2.1M |
Aug 15 - Aug 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4
| +13.03% | 200K |
—
|
—
| 1.73M |
May 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 4
| +2.78% | 50K |
$33.77 | $1,688,500.00 | 1.85M |
Mar 24
| |||
Form 4
|
∞
| 1.53M |
—
|
—
| 1.53M |
Mar 4
| |||
Form 4
| +2.86% | 50K |
$35.34 | $1,767,057.34 | 1.8M |
Mar 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4
| +2.89% | 49.13K |
$43.27 | $2,125,794.96 | 1.75M |
Jun 4
| |||
Form 4
| +2.70% | 44.65K |
$55.35 | $2,471,251.33 | 1.7M |
May 15 - May 19
| |||
Form 4
| +1.85% | 30K |
$50.00 | $1,500,000.00 | 1.65M |
Feb 10
| |||
Form 4
|
∞
| 1.93M |
—
|
—
| 1.93M |
May 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Lucira Health, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 1
| |||
Form 4
|
∞
| 146.38K |
—
|
—
| 146.38K |
Feb 9
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||